Mallia sets strategic course for future and completes €5.5 million financing
Summary
Mallia reorganized its business into a holding company with two subsidiaries focused on therapeutics and aesthetics. The company completed a €5.5 million seed financing round and plans to use the money mainly to develop cosmetic applications. Mallia Therapeutics will keep advancing an sCD83-based therapy for hair loss, while Mallia Aesthetics will develop cosmetic products for hair growth. The company also added Dr. Anne Asmuß and Dr. Stefan Strobl to the management teams of the subsidiaries. Mallia says it expects market entry for its cosmetic line in 2025.
Funding
Amount
$6.3M
Total raised
Date
June 4, 2025
Announcement date
Investors
-
Lead investors
Company
https://mallia.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected